Rosen Law Firm Encourages Capricor Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – Capr Business Wire (Press Release) 2d
Market movers: Nvidia, Advanced Micro Devices, Capricor Therapeutics, SpaceX… Proactive Investors (US) 2d
Capricor Therapeutics shares tumble after FDA reviewers raise concerns over Duchenne therapy Proactive Investors (US) 2d
FDA advisers dismiss safety warnings, back 4 peptide treatments Dermatology Advisor 1d Pharma Health All sources
FDA approves first OTC acetaminophen/Naproxen Sodium fixed-dose tablet Renal and Urology News 1d Tylenol Pharma All sources
A difficult-to-trace parasite, messaging missteps contribute to summer of overwhelming Cyclospora outbreaks Center for Infectious Disease Research and Policy 1d Mexico All sources
US FDA accepts octreotide depot NDA resubmission in acromegaly Rare Disease Advisor 1d Camurus Pharma CAM2029
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight MailOnline 1d Johnson & Johnson Article paywall
STAT Plus: FDA staff reiterate concerns about Replimune skin cancer treatment STAT 1d FDA Biotech Biotechnology
You can’t teach an old complaint new tricks Drug & Device Law 1d New Jersey Business New Jersey Crime New Jersey
